ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,69
-1,01%
Bitcoin
69 570,92
-2,63%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Invitae Corporation (NVTA)

  7. Invitae Corporation (NVTA) Actualités

NVTA

Invitae (NVTA)

Invitae Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:NVTA
DateHeureSourceTitreSymboleSociété
06/03/202414h31Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
30/01/202413h00PR Newswire (US)Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsNYSE:NVTAInvitae Corporation
29/01/202422h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:NVTAInvitae Corporation
24/01/202422h34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:NVTAInvitae Corporation
22/01/202413h00PR Newswire (US)Invitae Completes Sale of Reproductive Health Assets to NateraNYSE:NVTAInvitae Corporation
22/12/202303h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
13/12/202322h07PR Newswire (US)Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsNYSE:NVTAInvitae Corporation
15/11/202301h55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
08/11/202322h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVTAInvitae Corporation
08/11/202322h01PR Newswire (US)Invitae Reports Third Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
06/11/202322h00PR Newswire (US)Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research PartnershipsNYSE:NVTAInvitae Corporation
01/11/202311h59PR Newswire (US)Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NYSE:NVTAInvitae Corporation
25/10/202317h00PR Newswire (US)Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive ResultsNYSE:NVTAInvitae Corporation
19/10/202322h30PR Newswire (US)Invitae Appoints Dr. David Sholehvar as Chief Operating OfficerNYSE:NVTAInvitae Corporation
12/10/202322h15PR Newswire (US)Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast CancerNYSE:NVTAInvitae Corporation
10/10/202322h30PR Newswire (US)Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical GenomicsNYSE:NVTAInvitae Corporation
03/10/202318h07PR Newswire (US)Invitae's Common Hereditary Cancers Panel Receives FDA Market AuthorizationNYSE:NVTAInvitae Corporation
30/09/202302h00Dow Jones NewsFDA Gives Marketing Authorization to Invitae Test for Cancer GenesNYSE:NVTAInvitae Corporation
25/09/202322h30PR Newswire (US)Invitae Announces Appointment of Finance Veteran Ana Schrank as CFONYSE:NVTAInvitae Corporation
22/09/202322h30PR Newswire (US)Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing StandardNYSE:NVTAInvitae Corporation
28/08/202322h02PR Newswire (US)Invitae Hires Industry Veteran Robert Guigley as Chief Commercial OfficerNYSE:NVTAInvitae Corporation
15/08/202313h30PR Newswire (US)Clinical Trial Results Support Genetic Testing of All Patients with Prostate CancerNYSE:NVTAInvitae Corporation
14/08/202322h02PR Newswire (US)Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFONYSE:NVTAInvitae Corporation
10/08/202322h03Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:NVTAInvitae Corporation
10/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:NVTAInvitae Corporation
09/08/202315h22Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:NVTAInvitae Corporation
08/08/202322h01PR Newswire (US)Invitae Reports Second Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
26/07/202322h01PR Newswire (US)Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023NYSE:NVTAInvitae Corporation
03/07/202320h52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:NVTAInvitae Corporation
15/06/202322h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
 Showing the most relevant articles for your search:NYSE:NVTA

Dernières Valeurs Consultées

NASDAQI
INET
Strategic Internet of Th...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés